Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 37Prostatic Neoplasms 19Multiple Myeloma 17Neoplasm Metastasis 14Osteoporosis 8Neuroblastoma 6Pain 5Osteosarcoma 5Neoplasms, Plasma Cell 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Bone Diseases, Metabolic 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteonecrosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Giant Cell Tumor of Bone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Adenocarcinoma 2

Interventions

Denosumab 3Zoledronic Acid 2Indocyanine Green 2gentamicin-polymethylmethacrylate bead 1fludarabine 1aldesleukin 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Nivolumab 1Methods 1Ipilimumab 1Dasatinib 1Cyclophosphamide 1Curettage 1CTLA-4 Antigen 1Amputation, Surgical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Giant Cell Tumor of Bone × Zoledronic Acid × Clear all
NCT03295981 2026-04-22

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

St. Louis University

Phase 3 Recruiting
120 enrolled

Giant Cell Tumor of Bone

NCT00889590 2016-01-26

HR-GCT

Leiden University Medical Center

Phase 2 Terminated
15 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡